Progress in Intradermal and Transdermal Gene Therapy with Microneedles

Pharm Res. 2022 Oct;39(10):2475-2486. doi: 10.1007/s11095-022-03376-x. Epub 2022 Aug 25.

Abstract

Gene therapy is one of the most widely studied treatments and has the potential to treat a variety of intractable diseases. The skin's limited permeability, as the body's initial protective barrier, drastically inhibits the delivery effect of gene medicine. Given the potential adverse effects and physicochemical features of the medications, improving generic drug penetration into the skin barrier and achieving an effective level of target tissues remains a challenge. Microneedles have made tremendous improvements in aided gene transfer and medication delivery as a unique method. Microneedles offer the advantage of being minimally invasive and painless, as well as the ability to distribute gene medicines straight through the stratum corneum. Microneedles have been used to penetrate skin tissue with various nucleic acids and medicines in recent years, allowing for a wide range of applications in the treatment of skin ailments. This review focuses on skin-related disorders and immunity, and it primarily discusses the progress of microneedle transdermal gene therapy in recent years. It also complements the current major vectors and related microneedle gene therapy applications.

Keywords: gene delivery; gene therapy; microneedles; transdermal delivery.

Publication types

  • Review

MeSH terms

  • Administration, Cutaneous
  • Drug Delivery Systems / methods
  • Drugs, Generic*
  • Genetic Therapy / methods
  • Microinjections / methods
  • Needles / adverse effects
  • Nucleic Acids*
  • Pharmaceutical Preparations
  • Skin

Substances

  • Drugs, Generic
  • Nucleic Acids
  • Pharmaceutical Preparations